# Comparison of the Duration of Ropivacaine Combined With Dexmedetomidine or Dexamethasone on Paravertebral Block

> **NCT03570645** · PHASE4 · COMPLETED · sponsor: **China Medical University, China** · enrollment: 154 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Dexmedetomidine Group
- **DRUG:** dexamethasone group
- **DRUG:** control group

## Key facts

- **NCT ID:** NCT03570645
- **Lead sponsor:** China Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-12
- **Primary completion:** 2019-11-11
- **Final completion:** 2019-11-18
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2019-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03570645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03570645, "Comparison of the Duration of Ropivacaine Combined With Dexmedetomidine or Dexamethasone on Paravertebral Block". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03570645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*